Huysentruyt, Kristof http://orcid.org/0000-0002-2641-9382
Kjoersvik, Oeystein
Dobracki, Pawel
Savage, Elizabeth
Mishalov, Ellen
Cherry, Mark
Leonard, Eileen
Taylor, Robert
Patel, Bhavin
Abatemarco, Danielle
Article History
Accepted: 1 December 2020
First Online: 1 February 2021
Declarations
:
: This work was supported by TransCelerate BioPharma Inc.
: Kristof Huysentruyt is an employee and shareholder of UCB; Oeystein Kjoersvik is an employee of MSD, Czech Republic; Pawel Dobracki is an employee of Roche Products Limited; Elizabeth Savage is an employee of Janssen, the Pharmaceutical Companies of Johnson & Johnson; Ellen Mishalov is an employee of Astellas; Mark Cherry is an employee of AstraZeneca; Eileen Leonard is an employee of Bristol Myers Squibb; Robert Taylor is an employee of Merck & Co., Inc.; Bhavin Patel is an employee of Pfizer; and Danielle Abatemarco is an employee and shareholder of Bristol Myers Squibb.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the manuscript conception and design. All authors read and approved the final manuscript.